Cell-free DNA (cfDNA) analysis is transforming precision medicine, offering a non-invasive window into the body, particularly in the context of cancer. This journal collection, hosted by npj Precision ...

The following segment was excerpted from the Alger Mid Cap Focus Fund Q4 2025 Commentary.Class A shares of the Alger Mid Cap ...

Advancements in AI, multi-omics, and genome editing are transforming life sciences and biotechnology, addressing new ...

The FDA-approved comprehensive genomic profiling test will be reimbursed at a rate of $2,989.55 per test, helping to advance ...

Denmark's Octarine Bio has raised €5M ($5.8M) in new funding to launch precision-fermented pigments for food, textiles, and ...

Regulatory deregulation and liquid biopsy adoption pushing the rapid growth of the oncology companion diagnostic market. In ...

Illumina, Inc. today announced that reimbursement has been granted for its FDA-approved in vitro diagnostic (IVD) TruSighttm ...

Four innovation projects at KI in the field of life science receive funding from the Knut and Alice Wallenberg Foundation and ...